Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Sees Large Growth in Short Interest

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 301,151 shares, an increase of 6,375.0% from the December 15th total of 4,651 shares. Based on an average daily trading volume, of 105 shares, the days-to-cover ratio is currently 2,868.1 days. Based on an average daily trading volume, of 105 shares, the days-to-cover ratio is currently 2,868.1 days.

Shanghai Fosun Pharmaceutical (Group) Trading Up 11.2%

Shanghai Fosun Pharmaceutical (Group) stock opened at $2.78 on Wednesday. Shanghai Fosun Pharmaceutical has a 12-month low of $1.62 and a 12-month high of $3.50. The business’s 50-day moving average price is $3.10 and its two-hundred day moving average price is $2.86.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.